The Department of Veterans Affairs National Acquisition Center awarded Xlcare Pharmaceuticals Inc. a single-award indefinite delivery contract with a potential value of $23.8 million to supply montelukast sodium tablets. The base period of performance is May 10, 2021 through May 9, 2022 with four one-year option periods extending to May 9, 2025.
The contract aims to procure montelukast sodium tablets in 10mg strengths in package sizes of 30 bottles for individual use, 90 bottles for individual use, and 1000 bottle bulk packs. The tablets will be distributed through the VA's and DOD's pharmaceutical prime vendor programs to support the VA's Consolidated Mail Outpatient Pharmacy initiative and medical center needs. The pre-solicitation notice estimated annual tablet requirements of 175,261 bottles in 30 counts, 798,117 bottles in 90 counts, and 30,183 bottles in 1000 counts.
Xlcare Pharmaceuticals Inc. also holds additional indefinite delivery contracts with the VA, DOD, Bureau of Prisons, Indian Health Service and Federal Health Care Center to supply pharmaceutical products including gabapentin capsules, pantoprazole tablets, levetiracetam tablets, montelukast sodium tablets, and aripiprazole tablets. Xlcare further maintains Federal Supply Schedule 65IB to provide hematology drugs to VA hospitals through 2026.
Generated 3/17/24, 12:04 AM